Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Dr Martens Shares Plunge as Tough Outlook Sets Challenge for New CEO

Dr Martens Boots
Kenny Wilson, who has been at the helm for six years, has decided this year will be his last as CEO. (Shutterstock)

Dr Martens shares plunged around 30 percent on Tuesday to a record low after the British boot maker warned of another tough year in its key US market, setting a challenge for its next chief executive.

The company, whose chunky lace-up boots have been a fashion statement since the 1960s, named chief brand officer Ije Nwokorie as its next CEO.

Kenny Wilson, who has been at the helm for six years, has decided this year will be his last as CEO, Dr Martens said, although it did not give a precise date for the handover.

The company has been struggling with customer destocking and reduced orders in the United States from wholesale customers wary of economic pressures.

ADVERTISEMENT

Its shares have been hammered in recent years by a series of profit warnings and disappointing results that prompted investor Marathon Partners to call for an immediate strategic review earlier this month.

They hit a record low of 65.50 pence in early Tuesday trade.

Dr Martens said its results for the year ended March 31, 2024, would be in line with market expectations, but flagged another difficult year ahead.

“The FY25 outlook is challenging, and the whole organisation is focused on our action plan to reignite boots demand, particularly in the USA, our largest market,” Wilson said.

“The nature of USA wholesale is that when customers gain confidence in the market we will see a significant improvement in our business performance, but we are not assuming that this occurs in FY25.”

The company said it was anticipating a double-digit percentage decline in US wholesale revenues, which would dent overall profits.

It also said it did not expect to hike prices further this year, which had previously enabled it to offset cost inflation.

By Yadarisa Shabong and Eva Mathews; editing by Janane Venkatraman and Mark Potter

ADVERTISEMENT

Learn more:

Marathon Partners Pushes Dr. Martens for Strategic Review, Possible Sale

Investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company, according to a letter seen by Reuters.

In This Article
Topics
Organisations

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Retail
Analysis and advice from the front lines of the retail transformation.

The New Reality of Shipping to Saks

While $1.75 billion in court-approved funding has brought labels back to the fold, the real test for vendors will come when that temporary safety net vanishes later this year.


The Step-by-Step Guide to Brand Elevation | Case Study

A growing number of mass and premium brands are pushing upmarket with a more luxe look, better materials and, often, higher prices. This case study unpacks how these labels are navigating the tricky challenge of elevating a brand.


view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

Can Big Luxury Find Its New Look?

Sex sells — if anyone can figure out what sexy means in 2026. Robert Williams tracks the search for a new silhouette at Kering’s Gucci, LVMH’s Dior and more.


VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON